Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10226
CALL
Oceaneering
OII
$5.24B
| $154K | ﹤0.01% |
6,500
-19,000
| -75% | -$439K |
|
10227
Brown-Forman Class A
BF.A
$12.9B
| $153K | ﹤0.01% |
3,476
-2,034
| -37% | -$97K |
|
10228
CALL
Littelfuse
LFUS
$11.8B
| $153K | ﹤0.01% |
600
-1,800
| -75% | -$446K |
|
10229
Ramaco Resources Class B
METCB
$413M
| $153K | ﹤0.01% |
+15,225
| New | +$159K |
|
10230
CALL
Fidelity MSCI Materials Index ETF
FMAT
$611M
| $153K | ﹤0.01% |
+3,100
| New | +$158K |
|
10231
PUT
iShares MSCI Spain ETF
EWP
$2.26B
| $153K | ﹤0.01% |
4,900
-11,900
| -71% | -$383K |
|
10232
CALL
Glacier Bancorp
GBCI
$6.48B
| $153K | ﹤0.01% |
4,100
-1,100
| -21% | -$40.9K |
|
10233
Performance Shipping
PSHG
$22.6M
| $153K | ﹤0.01% |
+70,807
| New | +$153K |
|
10234
PUT
SunCoke Energy
SXC
$781M
| $153K | ﹤0.01% |
15,600
-5,300
| -25% | -$54.8K |
|
10235
PUT
PetMed Express
PETS
$38.4M
| $153K | ﹤0.01% |
37,700
-18,200
| -33% | -$77.7K |
|
|
MRNO
10236
Murano Global Investments
MRNO
$17.8M
| $153K | ﹤0.01% |
+15,971
| New | +$162K |
|
10237
CALL
Stoke Therapeutics
STOK
$2.04B
| $153K | ﹤0.01% |
11,300
-38,500
| -77% | -$520K |
|
|
ODP
10238
DELISTED
ODP
ODP
| $153K | ﹤0.01% |
+3,886
| New | +$173K |
|
10239
Mineralys Therapeutics
MLYS
$2.24B
| $152K | ﹤0.01% |
13,034
+12,937
| +13,337% | +$163K |
|
|
VTYX
10240
PUT
DELISTED
Ventyx Biosciences
VTYX
| $152K | ﹤0.01% |
66,000
+19,200
| +41% | +$79.8K |
|
|
CDMO
10241
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $152K | ﹤0.01% |
21,300
-29,200
| -58% | -$223K |
|
10242
CALL
Metallus
MTUS
$900M
| $152K | ﹤0.01% |
7,500
-1,200
| -14% | -$26.3K |
|
10243
CALL
Franklin Covey
FC
$225M
| $152K | ﹤0.01% |
4,000
+3,100
| +344% | +$116K |
|
10244
PUT
Baytex Energy
BTE
$3.09B
| $152K | ﹤0.01% |
43,600
-5,000
| -10% | -$17.9K |
|
10245
Kamada
KMDA
$447M
| $152K | ﹤0.01% |
30,304
+1,549
| +5% | +$8.17K |
|
10246
PUT
Clarus
CLAR
$139M
| $151K | ﹤0.01% |
22,500
-17,700
| -44% | -$117K |
|
10247
CALL
Banco Santander
SAN
$210B
| $151K | ﹤0.01% |
32,700
+10,900
| +50% | +$53.7K |
|
|
RVNC
10248
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $151K | ﹤0.01% |
58,900
-39,800
| -40% | -$136K |
|
10249
CALL
Artivion
AORT
$1.39B
| $151K | ﹤0.01% |
5,900
-12,100
| -67% | -$271K |
|
10250
BGSF Inc
BGSF
$61.1M
| $151K | ﹤0.01% |
+17,694
| New | +$143K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,759 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,759 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.